kohjin glutathione fatty liver S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression OPITAC™ Glutathione - KOHJIN Life

Here, we summarize the available experimental evidence supported by accumulating preclinical and clinical data that CA IX can contribute virtually to each step of cancer progression path via its enzyme activity and/or non-catalytic mechanisms

The mechanism involves regulating the expression of cell cycle-related proteins, such as inhibiting Cyclin D1 and upregulating cyclin suppressor proteins (such as p21), and thus blocking the proliferation cycle of cancer cells (111)

Regular follow-up is essential for monitoring treatment effectiveness and adjusting the injection schedule if needed

AO: Data curation, Funding acquisition, Resources, Visualization, Writing review & editing

& Zhou, L

Continuous monitoring of these contaminants is becoming more critical, especially as regulatory limits evolve